4-Fluoro-5-methoxy-DMT
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
4-Fluoro-5-Methoxy-N,N-dimethyltryptamine | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 312314-18-4 |
ATC code | ? |
Chemical data | |
Formula | C13H17FN2O |
Mol. mass | 236,13 g/mol |
(what is this?) (verify) | |
4-Fluoro-5-Methoxy-N,N-dimethyltryptamine (4-F-5-MeO-DMT) was first described by David E. Nichols team in 2000. It is a potent 5-HT1A agonist. Substitution with the 4-fluorine markedly increased 5-HT1A selectivity over 5-HT2A/2C receptors with potency greater than that of the 5-HT1A agonist 8-OH-DPAT.[1]
The analog compound with the N,N-dialkyl substituents constrained into a pyrrolidine ring, is a slightly stronger agonist for the 5-HT1A receptor and retains the selectivity over the 5-HT2A/2C receptors.[2]
See also
- 5-fluoro-AMT
- 6-fluoro-DMT
References
- ↑ Joseph B. Blair, Deborah Kurrasch-Orbaugh, Danuta Marona-Lewicka, Medhane G. Cumbay, Val J. Watts, Eric L. Barker, and David E. Nichols (2000). "Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines". Journal of Medicinal Chemistry 43 (24): 4701–4710. doi:10.1021/jm000339w. PMID 11101361.
- ↑ Uros Laban, Deborah Kurrasch-Orbaugh, Danuta Marona-Lewicka and David E. Nichols (2001). "A Novel Fluorinated Tryptamine with Highly Potent Serotonin 5-HT1A Receptor Agonist Properties". Bioorganic & Medicinal Chemistry Letters 11 (6): 793–795. doi:10.1016/S0960-894X(01)00062-2. PMID 11277522.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.